Switch to:
Abbott Laboratories (NYSE:ABT)
Accounts Payable
$5,997 Mil (As of Sep. 2015)

Abbott Laboratories's quarterly accounts payable increased from Mar. 2015 ($5,933 Mil) to Jun. 2015 ($5,994 Mil) and increased from Jun. 2015 ($5,994 Mil) to Sep. 2015 ($5,997 Mil).

Abbott Laboratories's annual accounts payable declined from Dec. 2012 ($10,889 Mil) to Dec. 2013 ($5,948 Mil) and declined from Dec. 2013 ($5,948 Mil) to Dec. 2014 ($5,415 Mil).


Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Abbott Laboratories Annual Data

Accts Payable 5,0264,9337,9447,82410,86812,10510,8895,9485,4150

Abbott Laboratories Quarterly Data

Accts Payable 6,1235,9485,6395,6495,5205,4155,9335,9945,9970
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership